Pacific Edge Limited - Latest News [Page 1]
Pacific Edge Launches Cxbladder Resolve
Thursday, 15 December 2016, 1:16 pm | Pacific Edge Limited
Cancer diagnostics company, Pacific Edge Limited (NZX: PEB) has today launched Cxbladder Resolve, the fourth product in the Cxbladder suite of bladder cancer diagnostic tests. More >>
PEB enters commercial agreement with Canterbury DHB
Wednesday, 9 March 2016, 10:43 am | Pacific Edge Limited
Cancer diagnostics company, Pacific Edge Limited (NZX:PEB) has entered into a commercial agreement to provide its innovative Cxbladder diagnostic technology to the Canterbury District Health Board (CDHB) for primary care referral in the evaluation of haematuria. ... More >>
Japan grants Pacific Edge patent for prognostic technology
Thursday, 25 September 2014, 10:35 am | Pacific Edge Limited
The world’s second largest single biomedical market, Japan, has awarded Pacific Edge a patent for its colorectal cancer prognostic technology. Pacific Edge Chief Executive Officer David Darling says the issue of the patent in Japan is a significant ... More >>
China Grants Patent For Detection of Gastric Cancer
Thursday, 23 May 2013, 12:49 pm | Pacific Edge Limited
China, with one of the highest incidences of stomach (Gastric) cancer in the world, has granted Pacific Edge Limited (the Company) its patent, ‘Detection of Gastric Cancer’. This patent defines technology that can be used for the diagnosis of gastric ... More >>
National Accounts Manager Appointed For USA
Thursday, 23 May 2013, 12:44 pm | Pacific Edge Limited
Michael Maltby has joined Pacific Edge Diagnostics USA (PEDUSA) as the new Director of National Accounts and Payer Relations. More >>